Mode
Text Size
Log in / Sign up
N/A N=49 Randomized Double-blind Treatment

Proclear 1-D Multifocal Nondispensing Study

Presbyopia

Enrolled (actual)
49
Serious AEs
0.0%
Results posted
Mar 2014
Primary outcome: Primary: Objective Vision Assessments: High Contrast Distance Visual Acuity — -0.09; -0.05 logMAR units

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
omafilcon A / PC 1-D MF (Device); lotrafilcon B / Air Optix MF (Device)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
May 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Objective Vision Assessments: High Contrast Distance Visual Acuity
-0.09; -0.05
PRIMARY
Objective Vision Assessments: High Contrast Intermediate Visual Acuity
-0.11; -0.10
PRIMARY
Objective Vision Assessments: High Contrast Near Visual Acuity
0.08; 0.05
SECONDARY
Subjective Overall Vision: High Contrast Distance Visual Quality
87; 88
SECONDARY
Subjective Vision Assessments: High Contrast Intermediate Visual Quality
85; 85
SECONDARY
Subjective Vision Assessments: High Contrast Near Visual Quality
81; 80

Summary

This study is designed to compare the relative performance related to subjective and objective vision between two multifocal soft contact lenses.

Eligibility Criteria

Inclusion Criteria

  • Be between 40 and 65 years of age (inclusive)
  • Require a reading addition of +1.25 to +2.50D (inclusive)
  • Spherical distance CL or spectacle prescription between +3.00D and -5.00D(inclusive)
  • Spectacle cylinder less than or equal to 0.75D in both eyes.
  • Currently has a reading add correction in their spectacle or CL habitual correction (e.g. if myope, removes distance correction to read)
  • Normal binocularity (no amblyopia, no strabismus, no habitually uncorrected anisometropia ≥ 2.00D)
  • Have a minimum 2 weeks soft contact lens experience
  • Be able to wear the study lens (e.g. good fit is attained and acceptable subjective comfort and vision for the duration of the study)
  • Able to read, comprehend and sign an informed consent
  • Willing to comply with the wear and study visit schedule
  • Monocular best-corrected distance visual acuity ≥ 20/25 in each eye
  • No gas permeable contact lens wear for 1 month prior to the study

Exclusion Criteria

To be eligible for the study, each candidate must not present with any of the following

  • Any active corneal infection, injury, inflammation, or ocular abnormality
  • Systemic or ocular allergies, which might interfere with contact lens wear
  • Systemic disease, which might interfere with contact lens wear
  • Ocular disease, which might interfere with contact lens wear
  • Pregnant or lactating
  • Strabismus/amblyopia
  • Habitually uncorrected anisometropia greater than or equal to 2.00 D
  • Subjects who have undergone corneal refractive surgery
  • Subjects with keratoconus or other severe corneal irregularity contraindicating lens wear
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01526902). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search